Medical Xpress news

Medical Xpress / Managing long COVID energy levels with a new activity-tracking app

The first study to test a digital tool designed to help people with long COVID manage their energy levels has been developed by a team of researchers. The paper published in Nature Communications is titled "A Digital Platform ...

Medical Xpress / A 'window to the brain': Chip tracks glioblastoma treatment response using tumor vesicles in blood

Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions. Dr. Richard Lobb and Dr. Zhen Zhang from UQ's Australian Institute ...

Feb 2, 2026 in Neuroscience
Medical Xpress / Taming tumor chaos: Researchers uncover key to improving glioblastoma treatment

A study by Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult brain cancer. The findings, published in ...

Feb 2, 2026 in Oncology & Cancer
Medical Xpress / Before crisis strikes—smartwatch tracks triggers for opioid misuse

Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for Disease Control and Prevention (CDC), in 2023, the nation recorded roughly 105,000 drug overdose deaths overall, ...

Feb 2, 2026 in Addiction
Medical Xpress / Targeting the 'good' arm after stroke can lead to better motor skills

Traditional stroke rehabilitation therapy focuses on restoring strength and movement to the more impaired side of the body, but a new randomized clinical trial has revealed that targeted therapy for the less impaired arm ...

Feb 2, 2026 in Neuroscience
Medical Xpress / Mutation map shows how key cancer gene drives tumor growth

Scientists have created a complete map showing how hundreds of possible mutations in a key cancer gene influence tumor growth. The study focused on CTNNB1, a gene that produces the protein β-catenin, which helps regulate ...

Feb 2, 2026 in Oncology & Cancer
Medical Xpress / Everyday diabetes medicine could treat common cause of blindness

Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the most common cause of blindness in western countries. In a recent study, ...

Feb 2, 2026 in Ophthalmology
Dialog / Can front-of-pack labels ease hospital strain? A Canadian blueprint as the U.S. considers FDA's Nutrition Info box

Hospital beds are a brutally concrete resource. When they're full, surgeries get delayed, hallways become overflow wards, and staff burn out. So a question I keep coming back to is simple: can the way we label food, those ...

Feb 2, 2026 in Health
Medical Xpress / It takes two: Genes ATP13A2 and GBA1 interact to drive neurodegeneration

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting more than 10 million people worldwide. People with this condition may experience tremors, limb stiffness, gait ...

Feb 2, 2026 in Neuroscience
Medical Xpress / Can metabolism tune heart aging? Findings suggest epigenetic switches can be reset

In order for heart and vascular cells to develop properly and remain healthy for a long time, many processes in the cells must interact precisely. A new study from the German Center for Cardiovascular Research (DZHK) now ...

Feb 2, 2026 in Genetics
Medical Xpress / Decoding the molecular signatures of night blindness

Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these mutations trigger complex, ...

Feb 2, 2026 in Genetics
Medical Xpress / 'Ghost' providers hinder access to health care for Medicaid patients

Almost one-third of physicians who are enrolled in Medicaid don't actually care for a single patient covered by Medicaid insurance, according to new research led by Oregon Health & Science University.

Feb 2, 2026 in Medical economics